nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—thyroid cancer	0.729	1	CbGaD
Ketorolac—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00671	0.155	CbGpPWpGaD
Ketorolac—PTGS2—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00532	0.123	CbGpPWpGaD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00504	0.116	CbGpPWpGaD
Ketorolac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.004	0.0923	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00274	0.0632	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00239	0.055	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00218	0.0501	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00182	0.042	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00145	0.0333	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00141	0.0326	CbGpPWpGaD
Ketorolac—Tiaprofenic acid—PTGS2—thyroid cancer	0.000959	0.179	CrCbGaD
Ketorolac—Nepafenac—PTGS2—thyroid cancer	0.000912	0.17	CrCbGaD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.000904	0.0209	CbGpPWpGaD
Ketorolac—Fenbufen—PTGS2—thyroid cancer	0.000873	0.163	CrCbGaD
Ketorolac—Salsalate—PTGS2—thyroid cancer	0.000758	0.142	CrCbGaD
Ketorolac—Tolmetin—PTGS2—thyroid cancer	0.000758	0.142	CrCbGaD
Ketorolac—Suprofen—PTGS2—thyroid cancer	0.000727	0.136	CrCbGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000708	0.0163	CbGpPWpGaD
Ketorolac—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.000588	0.0135	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000492	0.0113	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000461	0.0106	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000414	0.00955	CbGpPWpGaD
Ketorolac—Ketoprofen—PTGS2—thyroid cancer	0.00037	0.069	CrCbGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.00033	0.0076	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000327	0.00753	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000283	0.00653	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00026	0.006	CbGpPWpGaD
Ketorolac—Asthenia—Sorafenib—thyroid cancer	0.000253	0.00114	CcSEcCtD
Ketorolac—Cardiac failure—Doxorubicin—thyroid cancer	0.000251	0.00113	CcSEcCtD
Ketorolac—Pruritus—Sorafenib—thyroid cancer	0.000249	0.00112	CcSEcCtD
Ketorolac—Blood creatinine increased—Epirubicin—thyroid cancer	0.000248	0.00112	CcSEcCtD
Ketorolac—Hyponatraemia—Doxorubicin—thyroid cancer	0.000246	0.00111	CcSEcCtD
Ketorolac—Osteoarthritis—Doxorubicin—thyroid cancer	0.000245	0.0011	CcSEcCtD
Ketorolac—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000245	0.0011	CcSEcCtD
Ketorolac—Diplopia—Doxorubicin—thyroid cancer	0.000245	0.0011	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000245	0.00564	CbGpPWpGaD
Ketorolac—Liver function test abnormal—Epirubicin—thyroid cancer	0.000245	0.0011	CcSEcCtD
Ketorolac—Abdominal pain upper—Epirubicin—thyroid cancer	0.000242	0.00109	CcSEcCtD
Ketorolac—Migraine—Doxorubicin—thyroid cancer	0.000241	0.00109	CcSEcCtD
Ketorolac—Hypokalaemia—Epirubicin—thyroid cancer	0.000241	0.00109	CcSEcCtD
Ketorolac—Diarrhoea—Sorafenib—thyroid cancer	0.000241	0.00109	CcSEcCtD
Ketorolac—Breast disorder—Epirubicin—thyroid cancer	0.000239	0.00108	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000239	0.00107	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000239	0.00107	CcSEcCtD
Ketorolac—Nasopharyngitis—Epirubicin—thyroid cancer	0.000237	0.00107	CcSEcCtD
Ketorolac—Face oedema—Doxorubicin—thyroid cancer	0.000237	0.00107	CcSEcCtD
Ketorolac—Gastritis—Epirubicin—thyroid cancer	0.000234	0.00106	CcSEcCtD
Ketorolac—Dizziness—Sorafenib—thyroid cancer	0.000233	0.00105	CcSEcCtD
Ketorolac—Abdominal distension—Epirubicin—thyroid cancer	0.00023	0.00104	CcSEcCtD
Ketorolac—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00023	0.00103	CcSEcCtD
Ketorolac—Asthma—Epirubicin—thyroid cancer	0.000229	0.00103	CcSEcCtD
Ketorolac—Eosinophilia—Epirubicin—thyroid cancer	0.000227	0.00102	CcSEcCtD
Ketorolac—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000226	0.00102	CcSEcCtD
Ketorolac—Pancreatitis—Epirubicin—thyroid cancer	0.000224	0.00101	CcSEcCtD
Ketorolac—Vomiting—Sorafenib—thyroid cancer	0.000224	0.00101	CcSEcCtD
Ketorolac—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000224	0.00101	CcSEcCtD
Ketorolac—Hypokalaemia—Doxorubicin—thyroid cancer	0.000223	0.001	CcSEcCtD
Ketorolac—Rash—Sorafenib—thyroid cancer	0.000222	0.001	CcSEcCtD
Ketorolac—Dermatitis—Sorafenib—thyroid cancer	0.000222	0.000999	CcSEcCtD
Ketorolac—Breast disorder—Doxorubicin—thyroid cancer	0.000221	0.000997	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000221	0.000994	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000221	0.000994	CcSEcCtD
Ketorolac—Headache—Sorafenib—thyroid cancer	0.000221	0.000994	CcSEcCtD
Ketorolac—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000219	0.000987	CcSEcCtD
Ketorolac—Pancytopenia—Epirubicin—thyroid cancer	0.000217	0.000979	CcSEcCtD
Ketorolac—Gastritis—Doxorubicin—thyroid cancer	0.000217	0.000977	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000216	0.00497	CbGpPWpGaD
Ketorolac—Dysuria—Epirubicin—thyroid cancer	0.000214	0.000964	CcSEcCtD
Ketorolac—Abdominal distension—Doxorubicin—thyroid cancer	0.000213	0.00096	CcSEcCtD
Ketorolac—Asthma—Doxorubicin—thyroid cancer	0.000212	0.000954	CcSEcCtD
Ketorolac—Pollakiuria—Epirubicin—thyroid cancer	0.000211	0.000952	CcSEcCtD
Ketorolac—Eosinophilia—Doxorubicin—thyroid cancer	0.00021	0.000945	CcSEcCtD
Ketorolac—Nausea—Sorafenib—thyroid cancer	0.000209	0.000942	CcSEcCtD
Ketorolac—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000209	0.000941	CcSEcCtD
Ketorolac—Weight increased—Epirubicin—thyroid cancer	0.000208	0.000938	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000208	0.00479	CbGpPWpGaD
Ketorolac—Pancreatitis—Doxorubicin—thyroid cancer	0.000208	0.000935	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000207	0.00476	CbGpPWpGaD
Ketorolac—Hyperglycaemia—Epirubicin—thyroid cancer	0.000206	0.00093	CcSEcCtD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000205	0.00473	CbGpPWpGaD
Ketorolac—Pneumonia—Epirubicin—thyroid cancer	0.000205	0.000925	CcSEcCtD
Ketorolac—Drowsiness—Epirubicin—thyroid cancer	0.000204	0.000919	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000202	0.000911	CcSEcCtD
Ketorolac—Pancytopenia—Doxorubicin—thyroid cancer	0.000201	0.000906	CcSEcCtD
Ketorolac—Renal failure—Epirubicin—thyroid cancer	0.000201	0.000904	CcSEcCtD
Ketorolac—Stomatitis—Epirubicin—thyroid cancer	0.000199	0.000896	CcSEcCtD
Ketorolac—Jaundice—Epirubicin—thyroid cancer	0.000199	0.000896	CcSEcCtD
Ketorolac—Conjunctivitis—Epirubicin—thyroid cancer	0.000198	0.000894	CcSEcCtD
Ketorolac—Dysuria—Doxorubicin—thyroid cancer	0.000198	0.000892	CcSEcCtD
Ketorolac—Sweating—Epirubicin—thyroid cancer	0.000196	0.000881	CcSEcCtD
Ketorolac—Pollakiuria—Doxorubicin—thyroid cancer	0.000196	0.000881	CcSEcCtD
Ketorolac—Haematuria—Epirubicin—thyroid cancer	0.000195	0.000876	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000193	0.000871	CcSEcCtD
Ketorolac—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000193	0.000869	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—thyroid cancer	0.000193	0.000868	CcSEcCtD
Ketorolac—Epistaxis—Epirubicin—thyroid cancer	0.000193	0.000867	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000191	0.000861	CcSEcCtD
Ketorolac—Agranulocytosis—Epirubicin—thyroid cancer	0.00019	0.000858	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—thyroid cancer	0.00019	0.000856	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—thyroid cancer	0.000189	0.000851	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000187	0.000843	CcSEcCtD
Ketorolac—Bradycardia—Epirubicin—thyroid cancer	0.000187	0.00084	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000186	0.00428	CbGpPWpGaD
Ketorolac—Renal failure—Doxorubicin—thyroid cancer	0.000186	0.000836	CcSEcCtD
Ketorolac—Haemoglobin—Epirubicin—thyroid cancer	0.000184	0.000829	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—thyroid cancer	0.000184	0.000829	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—thyroid cancer	0.000184	0.000829	CcSEcCtD
Ketorolac—Rhinitis—Epirubicin—thyroid cancer	0.000184	0.000827	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—thyroid cancer	0.000184	0.000827	CcSEcCtD
Ketorolac—Hepatitis—Epirubicin—thyroid cancer	0.000183	0.000825	CcSEcCtD
Ketorolac—Haemorrhage—Epirubicin—thyroid cancer	0.000183	0.000825	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—thyroid cancer	0.000181	0.000815	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—thyroid cancer	0.000181	0.000815	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—thyroid cancer	0.00018	0.000811	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—thyroid cancer	0.00018	0.000811	CcSEcCtD
Ketorolac—PTGS1—Metabolism—MINPP1—thyroid cancer	0.00018	0.00415	CbGpPWpGaD
Ketorolac—Urethral disorder—Epirubicin—thyroid cancer	0.00018	0.000809	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000179	0.00412	CbGpPWpGaD
Ketorolac—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000179	0.000804	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—thyroid cancer	0.000178	0.000802	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—thyroid cancer	0.000177	0.000795	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—thyroid cancer	0.000176	0.000794	CcSEcCtD
Ketorolac—Erythema multiforme—Epirubicin—thyroid cancer	0.000173	0.00078	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—thyroid cancer	0.000173	0.000777	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—thyroid cancer	0.000171	0.000771	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—thyroid cancer	0.000171	0.000769	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—thyroid cancer	0.00017	0.000767	CcSEcCtD
Ketorolac—Flushing—Epirubicin—thyroid cancer	0.00017	0.000766	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—thyroid cancer	0.00017	0.000766	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—thyroid cancer	0.00017	0.000766	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—thyroid cancer	0.00017	0.000764	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—thyroid cancer	0.00017	0.000764	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000167	0.000754	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000167	0.00075	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—thyroid cancer	0.000166	0.000749	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—thyroid cancer	0.000166	0.000748	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—thyroid cancer	0.000166	0.000745	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—thyroid cancer	0.000165	0.000744	CcSEcCtD
Ketorolac—Chills—Epirubicin—thyroid cancer	0.000164	0.00074	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—thyroid cancer	0.000164	0.000737	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—thyroid cancer	0.000163	0.000736	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—thyroid cancer	0.000162	0.000729	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—thyroid cancer	0.000161	0.000723	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—thyroid cancer	0.00016	0.000722	CcSEcCtD
Ketorolac—Erythema—Epirubicin—thyroid cancer	0.00016	0.000718	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—thyroid cancer	0.00016	0.000718	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—thyroid cancer	0.000158	0.000714	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—thyroid cancer	0.000158	0.000712	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000158	0.00364	CbGpPWpGaD
Ketorolac—Flushing—Doxorubicin—thyroid cancer	0.000157	0.000709	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—thyroid cancer	0.000157	0.000709	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—thyroid cancer	0.000157	0.000708	CcSEcCtD
Ketorolac—Tension—Epirubicin—thyroid cancer	0.000157	0.000705	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—thyroid cancer	0.000156	0.000703	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—thyroid cancer	0.000155	0.000698	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.000155	0.00357	CbGpPWpGaD
Ketorolac—Back pain—Epirubicin—thyroid cancer	0.000154	0.000695	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—thyroid cancer	0.000154	0.000693	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—thyroid cancer	0.000153	0.00069	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000153	0.00353	CbGpPWpGaD
Ketorolac—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000153	0.000688	CcSEcCtD
Ketorolac—Chills—Doxorubicin—thyroid cancer	0.000152	0.000685	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—thyroid cancer	0.000151	0.000682	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—thyroid cancer	0.00015	0.000677	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—thyroid cancer	0.00015	0.000675	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—thyroid cancer	0.000149	0.000669	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—thyroid cancer	0.000148	0.000667	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—thyroid cancer	0.000148	0.000665	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—thyroid cancer	0.000148	0.000665	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—thyroid cancer	0.000147	0.000664	CcSEcCtD
Ketorolac—Agitation—Epirubicin—thyroid cancer	0.000147	0.00066	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—thyroid cancer	0.000145	0.000655	CcSEcCtD
Ketorolac—PTGS2—Disease—TRIM24—thyroid cancer	0.000145	0.00334	CbGpPWpGaD
Ketorolac—Tension—Doxorubicin—thyroid cancer	0.000145	0.000652	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—thyroid cancer	0.000145	0.000651	CcSEcCtD
Ketorolac—Malaise—Epirubicin—thyroid cancer	0.000144	0.000648	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CHST14—thyroid cancer	0.000144	0.00331	CbGpPWpGaD
Ketorolac—Nervousness—Doxorubicin—thyroid cancer	0.000143	0.000646	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—thyroid cancer	0.000143	0.000645	CcSEcCtD
Ketorolac—Syncope—Epirubicin—thyroid cancer	0.000143	0.000644	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—thyroid cancer	0.000143	0.000643	CcSEcCtD
Ketorolac—PTGS2—Metabolism—MINPP1—thyroid cancer	0.000143	0.00329	CbGpPWpGaD
Ketorolac—Back pain—Doxorubicin—thyroid cancer	0.000143	0.000643	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—thyroid cancer	0.000141	0.000635	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—thyroid cancer	0.00014	0.000631	CcSEcCtD
Ketorolac—Cough—Epirubicin—thyroid cancer	0.000139	0.000627	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—thyroid cancer	0.000139	0.000626	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—thyroid cancer	0.000138	0.000622	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—thyroid cancer	0.000138	0.00062	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000137	0.000617	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—thyroid cancer	0.000136	0.000614	CcSEcCtD
Ketorolac—PTGS2—Disease—CHST14—thyroid cancer	0.000136	0.00314	CbGpPWpGaD
Ketorolac—Myalgia—Epirubicin—thyroid cancer	0.000136	0.000612	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—thyroid cancer	0.000136	0.000612	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—thyroid cancer	0.000136	0.000612	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—thyroid cancer	0.000136	0.000611	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—thyroid cancer	0.000135	0.000609	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000135	0.000607	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—thyroid cancer	0.000134	0.000604	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	0.000133	0.00307	CbGpPWpGaD
Ketorolac—Malaise—Doxorubicin—thyroid cancer	0.000133	0.000599	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—thyroid cancer	0.000133	0.000598	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—thyroid cancer	0.000133	0.000597	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—thyroid cancer	0.000132	0.000596	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—thyroid cancer	0.000132	0.000595	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—thyroid cancer	0.000131	0.000591	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—thyroid cancer	0.00013	0.000587	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—thyroid cancer	0.00013	0.000586	CcSEcCtD
Ketorolac—Oedema—Epirubicin—thyroid cancer	0.00013	0.000586	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—thyroid cancer	0.00013	0.000584	CcSEcCtD
Ketorolac—Infection—Epirubicin—thyroid cancer	0.000129	0.000582	CcSEcCtD
Ketorolac—PTGS2—Disease—TRIM33—thyroid cancer	0.000129	0.00298	CbGpPWpGaD
Ketorolac—Cough—Doxorubicin—thyroid cancer	0.000129	0.00058	CcSEcCtD
Ketorolac—Shock—Epirubicin—thyroid cancer	0.000128	0.000577	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—thyroid cancer	0.000128	0.000576	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—thyroid cancer	0.000128	0.000575	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—thyroid cancer	0.000127	0.000574	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—thyroid cancer	0.000127	0.000574	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—thyroid cancer	0.000127	0.000572	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—thyroid cancer	0.000126	0.000569	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—thyroid cancer	0.000126	0.000567	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—thyroid cancer	0.000126	0.000566	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—thyroid cancer	0.000126	0.000566	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—thyroid cancer	0.000126	0.000566	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—thyroid cancer	0.000125	0.000564	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000125	0.000562	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—thyroid cancer	0.000124	0.000559	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—thyroid cancer	0.000124	0.000559	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—thyroid cancer	0.000123	0.000553	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—thyroid cancer	0.000122	0.000548	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—thyroid cancer	0.000121	0.000547	CcSEcCtD
Ketorolac—PTGS2—Metabolism—NDUFA13—thyroid cancer	0.000121	0.0028	CbGpPWpGaD
Ketorolac—Oedema—Doxorubicin—thyroid cancer	0.00012	0.000542	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00012	0.000542	CcSEcCtD
Ketorolac—Infection—Doxorubicin—thyroid cancer	0.00012	0.000539	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000119	0.000534	CcSEcCtD
Ketorolac—Shock—Doxorubicin—thyroid cancer	0.000119	0.000534	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—thyroid cancer	0.000118	0.000532	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000118	0.000531	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	0.000118	0.00272	CbGpPWpGaD
Ketorolac—Insomnia—Epirubicin—thyroid cancer	0.000118	0.00053	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—thyroid cancer	0.000118	0.000529	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—thyroid cancer	0.000117	0.000527	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—thyroid cancer	0.000117	0.000526	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000116	0.000524	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—thyroid cancer	0.000116	0.000523	CcSEcCtD
Ketorolac—PTGS1—Metabolism—HPGD—thyroid cancer	0.000116	0.00267	CbGpPWpGaD
Ketorolac—Somnolence—Epirubicin—thyroid cancer	0.000116	0.000521	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—thyroid cancer	0.000115	0.000517	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	0.000115	0.00264	CbGpPWpGaD
Ketorolac—Dyspepsia—Epirubicin—thyroid cancer	0.000115	0.000516	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CHST14—thyroid cancer	0.000114	0.00263	CbGpPWpGaD
Ketorolac—Decreased appetite—Epirubicin—thyroid cancer	0.000113	0.00051	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—thyroid cancer	0.000113	0.000507	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000112	0.000506	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—thyroid cancer	0.000112	0.000505	CcSEcCtD
Ketorolac—Pain—Epirubicin—thyroid cancer	0.000111	0.000501	CcSEcCtD
Ketorolac—Constipation—Epirubicin—thyroid cancer	0.000111	0.000501	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00011	0.000494	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—thyroid cancer	0.000109	0.000491	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—thyroid cancer	0.000108	0.000487	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—thyroid cancer	0.000107	0.000484	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—thyroid cancer	0.000107	0.000483	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—thyroid cancer	0.000107	0.000482	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000106	0.000479	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—thyroid cancer	0.000106	0.000478	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—thyroid cancer	0.000105	0.000472	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000104	0.000468	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—thyroid cancer	0.000104	0.000468	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—thyroid cancer	0.000103	0.000466	CcSEcCtD
Ketorolac—Pain—Doxorubicin—thyroid cancer	0.000103	0.000464	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—thyroid cancer	0.000103	0.000464	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—thyroid cancer	0.000103	0.000463	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—thyroid cancer	0.000103	0.000463	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—thyroid cancer	9.93e-05	0.000447	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—thyroid cancer	9.85e-05	0.000444	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	9.75e-05	0.00225	CbGpPWpGaD
Ketorolac—Hypersensitivity—Epirubicin—thyroid cancer	9.59e-05	0.000432	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—thyroid cancer	9.57e-05	0.000431	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—thyroid cancer	9.52e-05	0.000429	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—thyroid cancer	9.52e-05	0.000429	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.4e-05	0.00217	CbGpPWpGaD
Ketorolac—Asthenia—Epirubicin—thyroid cancer	9.34e-05	0.000421	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—thyroid cancer	9.21e-05	0.000415	CcSEcCtD
Ketorolac—PTGS2—Metabolism—HPGD—thyroid cancer	9.2e-05	0.00212	CbGpPWpGaD
Ketorolac—Diarrhoea—Epirubicin—thyroid cancer	8.91e-05	0.000401	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—thyroid cancer	8.87e-05	0.0004	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—thyroid cancer	8.64e-05	0.000389	CcSEcCtD
Ketorolac—PTGS2—Disease—TCF7L1—thyroid cancer	8.62e-05	0.00199	CbGpPWpGaD
Ketorolac—Dizziness—Epirubicin—thyroid cancer	8.61e-05	0.000388	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—thyroid cancer	8.52e-05	0.000384	CcSEcCtD
Ketorolac—Vomiting—Epirubicin—thyroid cancer	8.28e-05	0.000373	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—thyroid cancer	8.24e-05	0.000371	CcSEcCtD
Ketorolac—Rash—Epirubicin—thyroid cancer	8.21e-05	0.00037	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—thyroid cancer	8.2e-05	0.000369	CcSEcCtD
Ketorolac—Headache—Epirubicin—thyroid cancer	8.16e-05	0.000367	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.02e-05	0.00185	CbGpPWpGaD
Ketorolac—Dizziness—Doxorubicin—thyroid cancer	7.97e-05	0.000359	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	7.77e-05	0.00179	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.74e-05	0.00178	CbGpPWpGaD
Ketorolac—Nausea—Epirubicin—thyroid cancer	7.73e-05	0.000348	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—thyroid cancer	7.66e-05	0.000345	CcSEcCtD
Ketorolac—Rash—Doxorubicin—thyroid cancer	7.59e-05	0.000342	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—thyroid cancer	7.59e-05	0.000342	CcSEcCtD
Ketorolac—Headache—Doxorubicin—thyroid cancer	7.55e-05	0.00034	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.46e-05	0.00172	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—thyroid cancer	7.15e-05	0.000322	CcSEcCtD
Ketorolac—PTGS1—Metabolism—TPR—thyroid cancer	6.66e-05	0.00153	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PRKAR1A—thyroid cancer	6.55e-05	0.00151	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TPR—thyroid cancer	6.31e-05	0.00145	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRKAR1A—thyroid cancer	6.21e-05	0.00143	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	5.94e-05	0.00137	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.94e-05	0.00137	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MEN1—thyroid cancer	5.93e-05	0.00137	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TPR—thyroid cancer	5.28e-05	0.00122	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.28e-05	0.00122	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PRKAR1A—thyroid cancer	5.2e-05	0.0012	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC5A5—thyroid cancer	4.98e-05	0.00115	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CALCA—thyroid cancer	4.72e-05	0.00109	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.71e-05	0.00109	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.67e-05	0.00108	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.46e-05	0.00103	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDK1—thyroid cancer	4.28e-05	0.000986	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—RXRA—thyroid cancer	4.19e-05	0.000965	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.07e-05	0.000939	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC5A5—thyroid cancer	3.96e-05	0.000912	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NRG1—thyroid cancer	3.43e-05	0.000791	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RXRA—thyroid cancer	3.32e-05	0.000766	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.23e-05	0.000745	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TERT—thyroid cancer	3.08e-05	0.00071	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIF1A—thyroid cancer	2.95e-05	0.000679	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARG—thyroid cancer	2.64e-05	0.000609	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BRAF—thyroid cancer	2.44e-05	0.000563	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARG—thyroid cancer	2.1e-05	0.000484	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—thyroid cancer	2.08e-05	0.000479	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTEN—thyroid cancer	1.81e-05	0.000418	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTEN—thyroid cancer	1.72e-05	0.000396	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NRAS—thyroid cancer	1.53e-05	0.000354	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTEN—thyroid cancer	1.44e-05	0.000332	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—thyroid cancer	1.32e-05	0.000304	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HRAS—thyroid cancer	1.12e-05	0.000259	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—thyroid cancer	1.05e-05	0.000241	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—thyroid cancer	9.91e-06	0.000228	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—thyroid cancer	8.3e-06	0.000191	CbGpPWpGaD
